This website is no longer being updated. Please visit GBCHealth’s new website at:

Highlights from the PSD Retreat and September Global Fund Board Meeting

Private Sector Advisory Group members participated in the Annual PSD Retreat and Pre-Board meeting on September 10-11 in Lyon, France, to discuss the key Global Fund Board decisions. The Advisory Group also discussed broader issues facing the Fund, including organizational/governance reform, the search for a new executive director, options for the new funding model, a forecast of Global Fund assets and the future of the Affordable Medicines Facility- malaria. (AMFm is an innovative financing mechanism focused on increasing access to high quality anti-malarials.) The group discussed priorities for the PSD such as strengthening the partnership with the Global Fund Secretariat, private sector resource mobilization and the evolving role of the Focal Point. The retreat was graciously hosted by PSD Advisory Group member, Bayer.

An official delegation of Advisory Group members, led by Dr. Brian Brink (Private Sector Board member; Chief Medical Officer, Anglo American plc), went on to represent the private sector at the 27th Board meeting, from September 13-14 in Geneva, Switzerland. Major decisions from the Board meeting included:

  • Approval of the framework for the New Funding Model, which aims to increase the simplicity, flexibility and efficacy of grant-making. It will be structured around the following guiding principles: alignment with country strategies, proactive dialogue with applicants, focus on countries with a high disease burden and low ability to pay, and increased funding predictability. 
  • Global Fund Secretariat’s AMFm mandate: The Pilot Phase 1 of the initiative will expire at the end of 2012. The Global Fund Secretariat will continue hosting AMFm until December 31, 2013, to allow for a stable transition period. The Board was expected to decide in November whether to continue, modify or terminate AMFm. See highlights from the November Board Meeting (below) for additional details.
  • Revisions to the Policy on Ethics and Conflicts of Interest for GF Institutions were approved. 
  • Oversight of the Fund’s external audit and financial statements was reassigned from the Finance and Operational Performance Committee (FOPC) to the Audit and Ethics Committee (AEC).

Read more about the retreat and the Global Fund’s September Board Meeting here.